Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Nankai University

Headquarters: Tianjin, China
Year Founded: 1919
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Jan 28, 2025
Distillery Therapeutics

Inhibiting CD28 inside tumor cells for TNBC

BioCentury | Nov 8, 2024
Distillery Therapeutics

Inhibiting O-GlcNAcylation of YAP for diabetic retinopathy

BioCentury | Mar 12, 2024
Discovery & Translation

Distillery spotlight: new mitochondrial mechanisms from academia

Correcting mitochondrial dynamics, metabolic control of pathogenic or therapeutic cells emerge among translational innovations in BioCentury’s survey of 2023 publications
BioCentury | Mar 8, 2023
Distillery Therapeutics

MFN1 agonist for mitochondrial dysfunction

BioCentury | Jun 7, 2022
Distillery Therapeutics

Inhibiting PIT1 for urinary tract infection with E. coli

BioCentury | Mar 4, 2022
Distillery Therapeutics

Optimized generation of iPSC-derived islet cells for diabetes

BioCentury | Dec 19, 2018
Distillery Therapeutics

Cancer

BioCentury | Nov 13, 2018
Distillery Therapeutics

Infectious disease

BioCentury | Oct 25, 2018
Distillery Therapeutics

Cancer

Items per page:
1 - 10 of 14